Recurring earnings beat narrowly as guidance rises, but leverage and impairments temper the read

The quarter landed just above the published earnings bar. Adjusted EPS was $0.75 versus a published consensus near $0.73, while total revenue reached $120.8 million versus an external estimate around $113.5 million. That makes the headline a narrow beat, not a major upside surprise.

The recurring engine is improving, rather than the result relying only on a one-off gain. Adjusted Recurring Net Investment Income rose 26% to $107.0 million, supported by a larger portfolio, higher yields, and expanding co-investment fee income (Adjusted Recurring Net Investment Income). The portfolio yield increased to 9.2% from 8.2%, new Q2 transactions totaled approximately $1.1 billion, and the pipeline exceeded $6.5 billion (Portfolio and Investment Activity). That is the strongest part of the filing because it supports the earnings base management uses for future growth.

The guidance increase is constructive but modest. 2028 Adjusted EPS guidance moved to $3.55-$3.65 from $3.50-$3.60, lifting the midpoint by $0.05, while the company maintained its target for more than 17% Adjusted ROE in 2028 (Forward Guidance). The increase reflects better expected investment volumes, debt spreads, and fee income, but the small revision suggests an incremental reset rather than a transformational change.

The main offset is that growth is being financed with more expensive debt. Total debt increased to $5.9 billion from $4.7 billion year over year, while weighted-average interest cost rose to 6.2% from 5.8%; the company issued $600 million of junior subordinated notes, which receive partial equity credit but carry higher interest costs (Capital Structure). Leverage remained within the stated target at 1.7x, and 95% of debt was fixed-rate or hedged, limiting near-term rate sensitivity, but the higher funding burden is an important condition behind the growth story.

GAAP results look much noisier than the recurring economics. Six-month GAAP EPS fell to $0.43 from $1.18, despite six-month Adjusted EPS rising to $1.52 from $1.23, because equity-method income under HLBV accounting swung sharply and the company recorded a $70 million GAAP impairment on two equity investments (Income Statement; Adjusted Earnings Reconciliation; Portfolio Performance). Cash collections from those investments were $69 million in Q2 versus $68 million a year earlier, so the filing frames the impairment as an accounting mark rather than an operating collapse, but it still highlights the valuation and accounting risk embedded in the portfolio.

Net: a mildly positive update versus expectations. The narrow EPS and revenue beats, stronger recurring income, and small guidance raise outweigh the higher financing cost and $70 million impairment. The $0.425 quarterly dividend was maintained as a new Q3 declaration, but the filing also reiterates a longer-term plan for dividends to represent a smaller share of earnings (Dividend; Forward Guidance), making this more of a growth-and-reinvestment signal than a dividend-growth announcement.